- Forums
- ASX - By Stock
- SNT
- Ann: Interim data in Phase 2 study of SNT-5505 in myelofibrosis
SNT
syntara limited
Add to My Watchlist
0.00%
!
5.1¢

Ann: Interim data in Phase 2 study of SNT-5505 in myelofibrosis, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $82.87M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 37499 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.1¢ | 20000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 588335 | 0.051 |
7 | 741412 | 0.050 |
4 | 335097 | 0.049 |
3 | 471000 | 0.048 |
3 | 764000 | 0.047 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 300000 | 1 |
0.053 | 121870 | 4 |
0.054 | 350000 | 1 |
0.055 | 150000 | 1 |
0.056 | 44000 | 1 |
Last trade - 09.34am 30/06/2025 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online